US equities
|
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MSFT
$530.14
▼-0.16%
MU
$934.27
▼-4.98%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MSFT
$530.14
▼-0.16%
MU
$934.27
▼-4.98%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Astellas Pharma Inc
Recent news which mentions Astellas Pharma Inc
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Social issues
GSK plc
Healthy Returns
From
CNBC.com News
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
March 10, 2024
Tags
Biotechnology
Merck & Co Inc
Health care industry
From
CNBC.com News
Biden administration unveils first 10 drugs subject to Medicare price negotiations as it moves to cut costs
August 29, 2023
Tags
Law and Regulation
Seniors
Health care costs
From
CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
August 10, 2023
Tags
Biotechnology
Merck & Co Inc
AstraZeneca PLC
From
CNBC.com News